EP Patent

EP0268989A1 — Imidazopyridine compounds and processes for preparation thereof

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1988-06-01 · 38y expired

What this patent protects

An imidazopyridine compound of the formula : wherein R' is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R 2 is lower alkyl, R 3 is ar(lower)alkyl substituted by one or more substituent(s) selected from cyano, trihalo(lower)al…

USPTO Abstract

An imidazopyridine compound of the formula : wherein R' is lower alkynyl, lower alkynyloxy(lower)alkyl or N,N-di(lower)alkylamino(lower)alkynyl, R 2 is lower alkyl, R 3 is ar(lower)alkyl substituted by one or more substituent(s) selected from cyano, trihalo(lower)alkyl, carbamoyl, protected amino, carboxy, protected carboxy, hydroxy, hydroxy(lower)alkyl, protected hydroxy-(lower)alkyl, protected hydroxy and protected amino(lower)alkyl or ar(lower)alkyl substituted by lower alkyl and one additional substituent selected from hydroxy(lower)alkyl, amino, N-lower alkyl-N-protected amino, protected amino and lower alkylamino, and R 4 is hydrogen or lower alkyl, and a pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them. The invention also comprises intermediates of the formula and of the formula

Drugs covered by this patent

Patent Metadata

Patent number
EP0268989A1
Jurisdiction
EP
Classification
Expires
1988-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.